Cbd And Hemp

Congressional hearing addresses current state of CBD, but legal limbo continues

12-Apr-2024 By Danielle Masterson

FDA remains steadfast in its opinion that CBD is not a dietary supplement.

Industry demands closure to CBD regulation stalemate

09-Jan-2024 By Nikki Hancocks

The Association for the Cannabinoid Industry (ACI) has published a report calling on the UK Food Standards Agency (FSA) and the Home Office to work together to end the regulatory stalemate threatening the sector.

Legality of hemp-derived cannabinoids put on hold another year

05-Dec-2023 By Danielle Masterson

The recent stopgap extension of the Farm Bill means more of the same: Uncertainty for the US hemp industry.

CBD industry faces ‘existential crisis’

09-Nov-2023 By Claudia Adrien

Bethany Gomez, managing director of the Brightfield Group, spoke with NutraIngredients-USA about the difficulties the cannabidiol industry is experiencing when it comes to defining itself.

UK food law consultant: Don’t acquiesce to FSA’s new CBD dose opinion

23-Oct-2023 By Stephen Daniells

CBD industry stakeholders should not accept the UK Food Standards Agency’s recent downgrading of the CBD Acceptable Daily Intake (ADI), with recent studies advancing our understanding and potentially opening up opportunities to push for higher levels.

Bipartisan support for cannabidiol puts FDA, CBD coalitions in spotlight

26-Sep-2023 By Claudia Adrien

Advocates say there’s momentum in Congress to offer regulatory guidance for CBD supplement use.

New tox study validates safe upper dose for cbdMD’s Broad Spectrum CBD blend

25-Sep-2023 By Stephen Daniells

cbdMD's proprietary broad spectrum blend is safe when consumed as a dietary supplement in doses up to 160 mg per day in a 70 kg (154 lb), says a new study published in Regulatory Toxicology and Pharmacology.

Charlotte’s Web-Canopy Growth analysis identifies safe CBD intake levels for supplements

18-Sep-2023 By Claudia Adrien

Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.

‘The risk we have here is enough to manage’: Athlete turned entrepreneur Floyd Landis discusses how regulatory uncertainty threatens the global CBD industry

15-Sep-2023 By Oliver Morrison

Regulatory bottlenecks are threatening to hinder CBD innovation on both sides of the Atlantic, the former professional road racing cyclist Floyd Landis tells FoodNavigator.

Top CBD companies’ lackluster sales, profits point to years-long national trend

08-Sep-2023 By Claudia Adrien

The US cannabidiol industry has seen a year-over-year decline in sales, despite attempts to bolster the CBD market with newer products.

cbdMD CSO: ‘It appears that we’re finally making headway in Congress’

22-Aug-2023 By Stephen Daniells

The recent congressional hearing about CBD and subsequent ‘historic’ bicameral Request for Information (RFI) shows that hemp-derived CBD for use in dietary supplements has finally got the attention of Congress, said cbdMD’s CSO.

Pressure mounts on FDA to regulate CBD

31-Jul-2023 By Danielle Masterson

Lawmakers and stakeholders assembled for a congressional hearing on July 27 to highlight how FDA’s refusal to regulate CBD is threatening consumer access to safe products.

First-of-its-kind clinical trial supports CBD’s efficacy to boost sleep quality

13-Jun-2023 By Stephen Daniells

Four weeks of CBD (cannabidiol) supplementation at 15 mg per day led to clinically important improvement in their sleep quality, performing to a similar level to 5mg as melatonin, says a new study.

Guest Article

Ex-Health Canada NHP DG: ‘Cannabis is Canada’s New Wild West’

06-Jun-2023 By Adam Gibson, President, True Moderation

When it comes to regulating CBD and cannabis, Canada is an extreme cautionary tale for the US, says Adam Gibson, the former Director General of Health Canada’s Non-prescription and Natural Health Products Directorate.

CBD stakeholder’s call: “It’s really in Congress’ hands”

01-Jun-2023 By Danielle Masterson

With the ongoing theme of safety, FDA recently addressed CBD. While offering up several potential scenarios, the Agency said the CBD marketplace ultimately rests in the hands of Congress.

Floyd Landis on the industry issue that keeps him on at night

11-Apr-2023 By Danielle Masterson

CBD sellers were holding onto hope that the FDA would regulate CBD in order to stabilize the industry and give customers confidence, but the lack of guidance has left business owners like Landis feeling trapped.

Bipartisan house bills reintroduced to regulate CBD in food, dietary supplements

20-Mar-2023 By Danielle Masterson

Does the legislation have legs or is it just for optics? Stakeholders agree the bills are a step in a positive direction, but what impact they will have, if any, is yet to be seen.

DEA: Delta-8 and -9 THCO are controlled substances

02-Mar-2023 By Danielle Masterson

Once seen as a legal alternative to marijuana, the Agency is making it clear that synthetic cannabinoids are illegal under the Controlled Substances Act.

Expert opinion

ESSNA insights: CBD developments for the sports nutrition industry

16-Feb-2023 By Nikki Hancocks

The number of sports and active nutrition companies investing in CBD has grown significantly in Europe over the last few years despite regulatory uncertainty, so what does this market hold for these brands? In this article, ESSNA’s Chair Dr Adam Carey,...

NutraWomen Wednesday: Inesa Ponomariovaite, Founder, Nesa's Hemp

08-Feb-2023 By Danielle Masterson

She may be a serial entrepreneur, humanitarian, health coach and the founder of a hemp company, but perhaps what makes Inesa Ponomariovaite stand out the most is her incredible story of survival.

Brands gear up to work with Congress on CBD pathway

06-Feb-2023 By Danielle Masterson

As CBD rulemaking languishes, businesses experience frustration and uncertainty.

January Launch Pad: Chill mode activated

31-Jan-2023 By Danielle Masterson

Sleep and relaxation remain in high demand; and despite the lack of progress for CBD in Washington, brands are continuing to churn out product.

More trades react to sleepy FDA

30-Jan-2023 By Danielle Masterson

“FDA’s indecision has been the decision on CBD for far too long”

Drumroll, please… waiting game continues to plague CBD industry

26-Jan-2023 By Danielle Masterson

Rumors about a big FDA announcement began swirling earlier this week, with the industry bracing for a potential end to a five-year wait on the regulatory future of CBD. But, much like the last few years, CBD professionals were left waiting without answers,...

House Oversight chair to FDA: Enough is enough

17-Jan-2023 By Danielle Masterson

FDA’s failure to act on CBD created a space for bad actors and poor products to thrive, now the chairman—and the industry—want answers.

The hits keep coming on the CBD COVID claims jukebox

13-Jan-2023 By Hank Schultz

Despite President Biden infamously declaring that the COVID-19 pandemic is over, there is no shortage of CBD companies claiming to cure or treat the disease, as a glance at the latest warning letters shows.

NutraCast: Ingredients for a good night’s sleep

13-Jan-2023 By Danielle Masterson

With the new year in full swing, setting healthy goals is top of mind for many. And with more than 5 million Americans struggling to fall asleep each night, one major goal for some is getting enough rest. With so many ingredients to choose from, where...

Guest Article: NPA Chief on 2022’s industry sagas and what these mean for 2023

20-Dec-2022 By Daniel Fabricant, PhD. President & CEO, the Natural Products Association (NPA)

As social creatures were often reluctant to pick sides. It feels personal that we’re picking one person or group of people over another. However, for our industry, the reality is that there are divisive issues.

'A fantastic event': 6 reasons to attend NutraIngredients-USA’s Sports & Active Nutrition Summit 2023

12-Dec-2022 By Stephen Daniells

The Sports & Active Nutrition Summit 2023 is just two months away! Bridging the science and business of the sports and active nutrition categories, SANS is a must-attend event, and let us tell you why…

CBD in 2022: A year in review

06-Dec-2022 By Danielle Masterson

We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.

‘A continuing pattern of antagonism by FDA toward CBD in food and beverages’: Experts weigh in on recent warning letters

05-Dec-2022 By Stephen Daniells

The recent raft of warning letters to brands selling CBD-infused foods and beverages marked a shift in FDA approaches to the ingredient, with the Agency seeming to opine that food and beverages are “somehow a greater risk than supplements”.

'Quite frankly, I'm concerned for our entire industry...' FDA cracks down on firms selling CBD-infused foods & beverages in ‘aggressive’ new stance

22-Nov-2022 By Elaine Watson

The FDA has sent out a raft of warning letters to brands selling CBD-infused foods and beverages, adopting an “aggressive position” that one industry source told us made him “concerned for our entire industry.”

Sports & Active Nutrition Summit: Early bird discount expires this week

10-Nov-2022 By Stephen Daniells

With expert speakers confirmed from GNC, NOW, Advanced.gg, Floyds of Leadville, cbdMD, JSchall Consulting, TYM Performance, SPINS, NYU Tisch Institute for Global Sport, and more, the upcoming Sports & Active Nutrition Summit is not to be missed.

Charlotte’s Web announces partnership with MLB

13-Oct-2022 By Hank Schultz

Charlotte’s Web has passed a significant milestone by becoming the first CBD brand to enter into a partnership with Major League Baseball. it’s the first such sponsorship agreement for any CBD with a major sports league.

NutraCast: How amendments in the 2023 Farm Bill could shape the hemp industry

13-Oct-2022 By Danielle Masterson

Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?

CBD entrepreneur Floyd Landis to share vision in upcoming NutraIngredients-USA webinar

10-Oct-2022 By Hank Schultz

Some CBD entrepreneurs talk a good game when it comes to their companies’ mission statements. Former pro cyclist Floyd Landis has lived his.

Upcoming webinar to examine tumultuous CBD market

28-Sep-2022 By Hank Schultz

Demand for CBD ingredients remains high and innovation continues apace even as the regulatory uncertainty of the category persists. A panel of influential speakers will delve into these and other questions in an upcoming webinar hosted by NutraIngredients-USA.

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...

CBD brand Trip expands its foothold in US, launches gummies with $12m fundraise

26-Aug-2022 By Elizabeth Crawford

After dominating the UK CBD space with help from a highly engaged online fanbase, CBD beverage, oil and gummy brand Trip is hoping to cement a similar position in the US – but this time with the additional aid of $12m in funding from prominent entrepreneurs...

AHPA’s updated Hemp Lexicon seeks to shed light on ‘full spectrum’ question

25-Aug-2022 By Hank Schultz

The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Charlotte’s Web to hop on CBD sports bandwagon with new NSF-certified product line

15-Aug-2022 By Hank Schultz

CBD manufacturer Charlotte’s Web has announced the planned launch of a line of CBD products aimed at the sports market that will feature an NSF Certified for Sport mark.

Provisions of Senate bill could decimate hemp industry, industry group asserts

10-Aug-2022 By Hank Schultz

Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.

Congress explores how Farm Bill could hasten CBD regulations, market development

02-Aug-2022 By Elizabeth Crawford

On Capitol Hill last week, hemp industry stakeholders and Congressional leaders frustrated by FDA’s lack of regulations for CBD and other hemp-derived compounds since the 2018 Farm Bill authorized commercial production of the crop, explored how the 2023...

CBD: The ultimate celebrity side hustle

01-Jul-2022 By Danielle Masterson

Whether they’re an investor, founder or spokesperson, public figures such as athletes and actors are benefitting from CBD’s therapeutic properties –and its ability to bring in the dough.

Majority of CBD products tested in study found to have at least some THC

29-Jun-2022 By Hank Schultz

A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.

FDA revisits safety of CBD for use in dietary supplements, industry not satisfied

23-Jun-2022 By Asia Sherman

Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.

Kemin enters hemp-CBD space with Luxiva distillates range

15-Jun-2022 By Stephen Daniells

Iowa-based Kemin is expanding its portfolio to introduce a range of USDA-certified organic, traceable, U.S.-grown hemp CBD distillates for use in health and wellness products.

Nutracast: The van Breemen Company launches following groundbreaking hemp study

10-Jun-2022 By Danielle Masterson

Lead scientist Richard van Breemen, along with his co-founder and CEO Jacob Crabtree joined us to discuss the research that caught the world’s attention.

HempRise introduces 5% CBD nanoemulsion

09-Jun-2022 By Danielle Masterson

The vertically-integrated supplier of hemp extracts and cannabinoid ingredients recently introduced HempNANO, its new concentrated nanoemulsion for water soluble applications.

Study: Many CBD products would trigger doping bans

09-Jun-2022 By Shane Starling

Almost a third of 23 tested CBD products contained traces of banned cannabinoids at levels that would have provoked doping infringements, according to a just-published study.